Super Selective Adrenal Artery Embolization for Primary Aldosteronism: a Prospective Cohort Study(SAAE-PA)

Exclusion Criteria

• •A history of severe hypersensitivity to contrast media;
• •There are serious complications of liver disease, such as thrombocytopenia, esophageal variceal bleeding, etc;
• •Renal insufficiency (serum creatinine \> 176mmol/L or estimated glomerular filtration rate \< min.1.73m2);
• •Combined with other secondary hypertension, such as pheochromocytoma, hypercortisolism, renal vascular hypertension (such as renal artery stenosis), renin secretory tumor, renal parenchymatous hypertension, drug-induced hypertension (such as long-term use of glucocorticoids, contraceptives, estrogens, herbs containing glycyrrhizin), pregnancy hypertension and other secondary hypertension;
• •Hereditary diseases: such as false aldosteronism (Liddle syndrome), Bartter syndrome, familial hypokalemia and hypomagnesemia (Gitelman syndrome);
• •Cerebral apoplexy, myocardial infarction and stent implantation occurred in the past 3 months;
• •Serious other basic, such as heart dysfunction (grade IV), acute infection, autoimmune diseases, various malignant tumors and so on;
• •Participated in other clinical trials within the past 3 months;
• •Individual pregnancy, nursing or planning pregnancy;